|
Anti-tumor efficacy of a bevacizumab preconditioning followed by etoposide and cisplatin regimen in human epidermal growth factor receptor-2-positive breast cancer brain metastasis refractory to whole brain radiotherapy
Tom Wei-Wu Chen1, Ching-Hung Lin2, Dah-Cherng Yeh3, Ling-Ming Tseng4, Kun-Ming Rau5, Bang-Bin Chen6, Ta-Chung Chao7, Shu-Min Huang8, Dwan-Ying Chang9, I-Chun Chen1, Ann-Lii Cheng10, Yen-Shen Lu2
1 Department of Oncology, National Taiwan University Hospital; Department of Medical Oncology, National Taiwan University Cancer Center; Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan
2 Department of Oncology, National Taiwan University Hospital; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan
3 Breast Medical Center, Cheng Ching Hospital, Taichung, Taiwan
4 Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan
5 Department of Hematology Oncology, E-Da Cancer Hospital, Kaohsiung, Taiwan
6 Department of Medical Imaging, National Taiwan University Hospital, Taipei, Taiwan
7 Department of Oncology, Taipei Veterans General Hospital, Taipei, Taiwan
8 Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan
9 Department of Oncology, National Taiwan University Hospital; Department of Medical Oncology, National Taiwan University Cancer Center, Taipei, Taiwan
10 Department of Oncology, National Taiwan University Hospital; Department of Medical Oncology, National Taiwan University Cancer Center; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan
Correspondence Address:
Prof. Yen-Shen Lu
Department of Oncology, National Taiwan University Hospital, 7, Chung-Shan South Road, Taipei
Taiwan
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/ejcrp.eJCRP-D-23-00001
|
